Long-term outcomes of autoimmune pancreatitis: A multicentre, international analysis

Phil A. Hart, Terumi Kamisawa, William R. Brugge, Jae Bock Chung, Emma L. Culver, L. Czakó, Luca Frulloni, Vay Liang W Go, Thomas M. Gress, Myung Hwan Kim, Shigeyuki Kawa, Kyu Taek Lee, Markus M. Lerch, Wei Chih Liao, Matthias Löhr, Kazuichi Okazaki, Ji Kon Ryu, Nicolas Schleinitz, Kyoko Shimizu, Tooru ShimosegawaRoy Soetikno, George Webster, Dhiraj Yadav, Yoh Zen, Suresh T. Chari

Research output: Article

271 Citations (Scopus)

Abstract

Objective: Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multinational analysis. A total of 1064 patients meeting the International Consensus Diagnostic Criteria for type 1 (n=978) or type 2 (n=86) AIP were included. Data regarding treatments, relapses and sequelae were obtained. Results: The majority of patients with type 1 (99%) and type 2 (92%) AIP who were treated with steroids went into clinical remission. Most patients with jaundice required biliary stent placement (71% of type 1 and 77% of type 2 AIP). Relapses were more common in patients with type 1 (31%) versus type 2 AIP (9%, p

Original languageEnglish
Pages (from-to)1771-1776
Number of pages6
JournalGut
Volume62
Issue number12
DOIs
Publication statusPublished - dec. 2013

Fingerprint

Pancreatitis
Recurrence
Chronic Pancreatitis
Jaundice
Stents
Steroids
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hart, P. A., Kamisawa, T., Brugge, W. R., Chung, J. B., Culver, E. L., Czakó, L., ... Chari, S. T. (2013). Long-term outcomes of autoimmune pancreatitis: A multicentre, international analysis. Gut, 62(12), 1771-1776. https://doi.org/10.1136/gutjnl-2012-303617

Long-term outcomes of autoimmune pancreatitis : A multicentre, international analysis. / Hart, Phil A.; Kamisawa, Terumi; Brugge, William R.; Chung, Jae Bock; Culver, Emma L.; Czakó, L.; Frulloni, Luca; Go, Vay Liang W; Gress, Thomas M.; Kim, Myung Hwan; Kawa, Shigeyuki; Lee, Kyu Taek; Lerch, Markus M.; Liao, Wei Chih; Löhr, Matthias; Okazaki, Kazuichi; Ryu, Ji Kon; Schleinitz, Nicolas; Shimizu, Kyoko; Shimosegawa, Tooru; Soetikno, Roy; Webster, George; Yadav, Dhiraj; Zen, Yoh; Chari, Suresh T.

In: Gut, Vol. 62, No. 12, 12.2013, p. 1771-1776.

Research output: Article

Hart, PA, Kamisawa, T, Brugge, WR, Chung, JB, Culver, EL, Czakó, L, Frulloni, L, Go, VLW, Gress, TM, Kim, MH, Kawa, S, Lee, KT, Lerch, MM, Liao, WC, Löhr, M, Okazaki, K, Ryu, JK, Schleinitz, N, Shimizu, K, Shimosegawa, T, Soetikno, R, Webster, G, Yadav, D, Zen, Y & Chari, ST 2013, 'Long-term outcomes of autoimmune pancreatitis: A multicentre, international analysis', Gut, vol. 62, no. 12, pp. 1771-1776. https://doi.org/10.1136/gutjnl-2012-303617
Hart, Phil A. ; Kamisawa, Terumi ; Brugge, William R. ; Chung, Jae Bock ; Culver, Emma L. ; Czakó, L. ; Frulloni, Luca ; Go, Vay Liang W ; Gress, Thomas M. ; Kim, Myung Hwan ; Kawa, Shigeyuki ; Lee, Kyu Taek ; Lerch, Markus M. ; Liao, Wei Chih ; Löhr, Matthias ; Okazaki, Kazuichi ; Ryu, Ji Kon ; Schleinitz, Nicolas ; Shimizu, Kyoko ; Shimosegawa, Tooru ; Soetikno, Roy ; Webster, George ; Yadav, Dhiraj ; Zen, Yoh ; Chari, Suresh T. / Long-term outcomes of autoimmune pancreatitis : A multicentre, international analysis. In: Gut. 2013 ; Vol. 62, No. 12. pp. 1771-1776.
@article{c17d69527df54ab3be705446a0e1f2f0,
title = "Long-term outcomes of autoimmune pancreatitis: A multicentre, international analysis",
abstract = "Objective: Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multinational analysis. A total of 1064 patients meeting the International Consensus Diagnostic Criteria for type 1 (n=978) or type 2 (n=86) AIP were included. Data regarding treatments, relapses and sequelae were obtained. Results: The majority of patients with type 1 (99{\%}) and type 2 (92{\%}) AIP who were treated with steroids went into clinical remission. Most patients with jaundice required biliary stent placement (71{\%} of type 1 and 77{\%} of type 2 AIP). Relapses were more common in patients with type 1 (31{\%}) versus type 2 AIP (9{\%}, p",
author = "Hart, {Phil A.} and Terumi Kamisawa and Brugge, {William R.} and Chung, {Jae Bock} and Culver, {Emma L.} and L. Czak{\'o} and Luca Frulloni and Go, {Vay Liang W} and Gress, {Thomas M.} and Kim, {Myung Hwan} and Shigeyuki Kawa and Lee, {Kyu Taek} and Lerch, {Markus M.} and Liao, {Wei Chih} and Matthias L{\"o}hr and Kazuichi Okazaki and Ryu, {Ji Kon} and Nicolas Schleinitz and Kyoko Shimizu and Tooru Shimosegawa and Roy Soetikno and George Webster and Dhiraj Yadav and Yoh Zen and Chari, {Suresh T.}",
year = "2013",
month = "12",
doi = "10.1136/gutjnl-2012-303617",
language = "English",
volume = "62",
pages = "1771--1776",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Long-term outcomes of autoimmune pancreatitis

T2 - A multicentre, international analysis

AU - Hart, Phil A.

AU - Kamisawa, Terumi

AU - Brugge, William R.

AU - Chung, Jae Bock

AU - Culver, Emma L.

AU - Czakó, L.

AU - Frulloni, Luca

AU - Go, Vay Liang W

AU - Gress, Thomas M.

AU - Kim, Myung Hwan

AU - Kawa, Shigeyuki

AU - Lee, Kyu Taek

AU - Lerch, Markus M.

AU - Liao, Wei Chih

AU - Löhr, Matthias

AU - Okazaki, Kazuichi

AU - Ryu, Ji Kon

AU - Schleinitz, Nicolas

AU - Shimizu, Kyoko

AU - Shimosegawa, Tooru

AU - Soetikno, Roy

AU - Webster, George

AU - Yadav, Dhiraj

AU - Zen, Yoh

AU - Chari, Suresh T.

PY - 2013/12

Y1 - 2013/12

N2 - Objective: Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multinational analysis. A total of 1064 patients meeting the International Consensus Diagnostic Criteria for type 1 (n=978) or type 2 (n=86) AIP were included. Data regarding treatments, relapses and sequelae were obtained. Results: The majority of patients with type 1 (99%) and type 2 (92%) AIP who were treated with steroids went into clinical remission. Most patients with jaundice required biliary stent placement (71% of type 1 and 77% of type 2 AIP). Relapses were more common in patients with type 1 (31%) versus type 2 AIP (9%, p

AB - Objective: Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae. Design 23 institutions from 10 different countries participated in this multinational analysis. A total of 1064 patients meeting the International Consensus Diagnostic Criteria for type 1 (n=978) or type 2 (n=86) AIP were included. Data regarding treatments, relapses and sequelae were obtained. Results: The majority of patients with type 1 (99%) and type 2 (92%) AIP who were treated with steroids went into clinical remission. Most patients with jaundice required biliary stent placement (71% of type 1 and 77% of type 2 AIP). Relapses were more common in patients with type 1 (31%) versus type 2 AIP (9%, p

UR - http://www.scopus.com/inward/record.url?scp=84887443321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887443321&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2012-303617

DO - 10.1136/gutjnl-2012-303617

M3 - Article

C2 - 23232048

AN - SCOPUS:84887443321

VL - 62

SP - 1771

EP - 1776

JO - Gut

JF - Gut

SN - 0017-5749

IS - 12

ER -